Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
TransUnion EVP, Chief Global Solutions Mohamed Abdelsadek Sells $15.6K of Stock
Mohamed Abdelsadek, EVP, Chief Global Solutions, sold 250 shares of TransUnion at $62.29 a share, worth $15.6K in total on Oct 1, 2026. Shares held after the trade: 53,181 (-0.5%).
Alkermes EVP, CLO, Alkermes, Inc. David Joseph Gaffin Sells $83.5K of Stock
David Joseph Gaffin, EVP, CLO, Alkermes, Inc., sold 2,034 shares of Alkermes plc. at $41.03 a share, worth $83.5K in total on Oct 2, 2026. Shares held after the trade: 221,388 (-0.9%).
AvePoint CLO Brian Michael Brown Sells $141K of Stock
Brian Michael Brown, CLO, sold 10,000 shares of AvePoint, Inc. at $14.11 a share, worth $141K in total on Sep 30, 2026. Shares held after the trade: 364,604 (-2.7%).
Planet Labs PBC Director Ita M. Brennan Sells $187K of Stock
Ita M. Brennan, Director, sold 11,500 shares of Planet Labs PBC at $16.30 a share, worth $187K in total on Oct 1, 2026. Shares held after the trade: 250,373 (-4.4%).
Alphabet Director Frances Arnold Sells $28.3K of Stock
Frances Arnold, Director, sold 83 shares of Alphabet Inc. at $340.45 a share, worth $28.3K in total on Sep 30, 2026. Shares held after the trade: 19,076 (-0.4%).
PennyMac Mortgage Investment Trust CAO Gregory L. Hendry Sells $19.2K of Stock
Gregory L. Hendry, CAO, sold 2,444 shares of PennyMac Mortgage Investment Trust at $7.86 a share, worth $19.2K in total on Oct 1, 2026. Shares held after the trade: 4,886 (-33.3%).
Roblox Insider Gregory Baszucki Sells $714K of Stock
Gregory Baszucki sold 16,666 shares of Roblox Corp at $42.57 to $43.03 a share (average $42.87) in 4 transactions, worth $714K in total on Oct 1, 2026. Shares held after the trade: 1,252,836 (-0.4%).
Mineralys Therapeutics CEO Jon Congleton Sells $1.91M of Stock
Jon Congleton, CEO, sold 75,000 shares of Mineralys Therapeutics, Inc. at $25.46 a share, worth $1.91M in total on Sep 30, 2026. Shares held after the trade: 528,621 (-12.4%).
Rivian Automotive Chief Administrative Officer Michael John Callahan Sells $225K of Stock
Michael John Callahan, Chief Administrative Officer, sold 15,000 shares of Rivian Automotive, Inc. at $15.00 a share, worth $225K in total on Oct 1, 2026. Shares held after the trade: 1,001,776 (-1.5%).
Oric Pharmaceuticals Director Richard A. Heyman Sells $86.5K of Stock
Richard A. Heyman, Director, sold 6,700 shares of Oric Pharmaceuticals, Inc. at $12.91 a share, worth $86.5K in total on Oct 1, 2026. Shares held after the trade: 203,472 (-1.5%).
Rubrik Director John Wendell Thompson Sells $1.56M of Stock
John Wendell Thompson, Director, sold 13,500 shares of Rubrik, Inc. at $114.68 to $116.47 a share (average $115.69) in 6 transactions, worth $1.56M in total on Oct 1, 2026. Shares held after the trade: 8,362 (-22.3%).
Cactus Chairman and CEO Scott Bender Sells $6.2M of Stock
Scott Bender, Chairman and CEO, sold 100,000 shares of Cactus, Inc. at $61.97 a share, worth $6.2M in total on Oct 1, 2026. Shares held after the trade: 120,527 (-45.3%).
Joel Bender, President, sold 100,000 shares of Cactus, Inc. at $61.97 a share, worth $6.2M in total on Oct 1, 2026. Shares held after the trade: 41,519 (-70.7%).
First Solar CTO Markus Gloeckler Sells $139K of Stock
Markus Gloeckler, CTO, sold 800 shares of First Solar, Inc. at $174.00 a share, worth $139K in total on Oct 1, 2026. Shares held after the trade: 5,042 (-13.7%).
Anaptysbio Director Hollings Renton Sells $249K of Stock
Hollings Renton, Director, sold 5,000 shares of Anaptysbio, Inc at $49.87 a share, worth $249K in total on Oct 1, 2026. Shares held after the trade: 10,995 (-31.3%).
Roivant Sciences President & Immunovant CEO Eric Venker Sells $7.32M of Stock
Eric Venker, President & Immunovant CEO, sold 200,000 shares of Roivant Sciences Ltd. at $36.62 a share, worth $7.32M in total on Sep 30, 2026. Shares held after the trade: 1,599,154 (-11.1%).
Stoke Therapeutics General Counsel & Corp Sec Jonathan Allan Sells $16.5K of Stock
Jonathan Allan, General Counsel & Corp Sec, sold 627 shares of Stoke Therapeutics, Inc. at $26.33 a share, worth $16.5K in total on Oct 2, 2026. Shares held after the trade: 20,598 (-3.0%).
Stoke Therapeutics CMO Barry Ticho Sells $27.5K of Stock
Barry Ticho, CMO, sold 1,051 shares of Stoke Therapeutics, Inc. at $26.16 a share, worth $27.5K in total on Oct 1, 2026. Shares held after the trade: 19,059 (-5.2%).
Walmart EVP Daniel J. Bartlett Sells $417K of Stock
Daniel J. Bartlett, EVP, sold 3,990 shares of Walmart Inc. at $104.41 a share, worth $417K in total on Oct 1, 2026. Shares held after the trade: 618,359 (-0.6%).
Amit Gupta, CEO, sold 17,733 shares of Cardlytics, Inc. at $2.53 to $2.71 a share (average $2.64) in 2 transactions, worth $46.7K in total between Oct 1, 2026 and Oct 2, 2026. Shares held after the trade: 138,906 (-5.0%).
Nurix Therapeutics CLO Christine Ring Sells $134K of Stock
Christine Ring, CLO, sold 5,786 shares of Nurix Therapeutics, Inc. at $23.19 a share, worth $134K in total on Oct 2, 2026. Shares held after the trade: 9,110 (-38.8%).
PTC Therapeutics Director Glenn Steele Jr. Md. Phd. Sells $782K of Stock
Glenn Steele Jr. Md. Phd., Director, sold 12,000 shares of PTC Therapeutics, Inc. at $65.16 a share, worth $782K in total on Sep 30, 2026. Shares held after the trade: 22,500 (-34.8%).
Rocket Lab CFO Adam C. Spice Sells $9.93M of Stock
Adam C. Spice, CFO, sold 140,157 shares of Rocket Lab Corp at $70.28 to $71.79 a share (average $70.82) in 3 transactions, worth $9.93M in total on Oct 1, 2026. Shares held after the trade: 1,155,967 (-1.3%).
Raymond Woo, CTO, sold 4,887 shares of Ceribell, Inc. at $24.38 a share, worth $119K in total on Oct 1, 2026. Shares held after the trade: 203,118 (-2.3%).
Oramed Pharmaceuticals CFO Avraham Gabay Sells $90.2K of Stock
Avraham Gabay, CFO, sold 20,000 shares of Oramed Pharmaceuticals Inc. at $4.51 a share, worth $90.2K in total on Oct 1, 2026. Shares held after the trade: 861,076 (-2.3%).
Joshua Hexter, COO & Cbo, sold 30,000 shares of Oramed Pharmaceuticals Inc. at $4.51 a share, worth $135K in total on Oct 1, 2026. Shares held after the trade: 1,328,130 (-2.2%).
Verastem President and CEO Dan Paterson Sells $353K of Stock
Dan Paterson, President and CEO, sold 44,121 shares of Verastem, Inc. at $8.00 a share, worth $353K in total on Oct 1, 2026. Shares held after the trade: 652,712 (-6.3%).
Daniel Calkins, CFO, sold 2,566 shares of Verastem, Inc. at $8.00 a share, worth $20.5K in total on Oct 1, 2026. Shares held after the trade: 123,781 (-2.0%).
Coursera President & CEO Gregory M. Hart Sells $52.6K of Stock
Gregory M. Hart, President & CEO, sold 10,308 shares of Coursera, Inc. at $5.11 a share, worth $52.6K in total on Oct 1, 2026. Shares held after the trade: 1,539,003 (-0.7%).
Generac Holdings CEO Aaron Jagdfeld Sells $1.03M of Stock
Aaron Jagdfeld, CEO, sold 5,000 shares of Generac Holdings Inc. at $206.00 a share, worth $1.03M in total on Oct 1, 2026. Shares held after the trade: 544,528 (-0.9%).